Exploring the Quality of Life Benefits of Subcutaneous C1-Inhibitor (C1-INH) Replacement Therapy Using Qualitative Research Methods

被引：0
|
作者：
Anderson, John T. [1 ]
Levy, Donald S. [2 ]
Lumry, William R. [3 ]
Koochaki, Patricia [4 ]
Lanar, Sally [5 ]
Li, H. Henry [6 ]
机构：
[1] Alabama Allergy & Asthma Ctr, Birmingham, AL USA
[2] UC Irvine, Orange, CA USA
[3] AARA Res Ctr, Dallas, TX USA
[4] ICON, Cincinnati, OH USA
[5] ICON, Lyon, France
[6] Inst Asthma & Allergy, Chevy Chase, MD USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
132
引用
收藏
页码：AB45 / AB45
页数：1
相关论文
共 50 条
  • [41] Long-term Health-related Quality of Life in Patients Treated With Subcutaneous C1-Inhibitor Replacement Therapy for the Prevention of Hereditary Angioedema Attacks
    Lumry, William R.
    Craig, Timothy J.
    Magerl, Markus A. K.
    Farkas, Henriette
    Lawo, John-Philip
    Chiao, Joseph
    Machnig, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB39 - AB39
  • [42] Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases)
    Fragnan, N. T. M. L.
    Tolentino, A. L. N.
    Borba, G. B.
    Oliveira, A. C.
    Simoes, J. A.
    Palma, S. M. U.
    Constantino-Silva, R. N.
    Grumach, A. S.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2018, 51 (12)
  • [43] LONG-TERM PROPHYLAXIS WITH C1-INHIBITOR (C1 INH) CONCENTRATE IN PATIENTS WITH RECURRENT ANGIOEDEMA CAUSED BY HEREDITARY AND ACQUIRED C1-INHIBITOR DEFICIENCY
    BORK, K
    WITZKE, G
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (03) : 677 - 682
  • [44] PASTEURIZED, NANOFILTERED C1-ESTERASE INHIBITOR FORANGIOEDEMA DUE TO ACQUIRED C1-INH DEFICIENCY
    Farkas, H.
    Molnar, K.
    Horvath, L.
    Csuka, D.
    Zotter, Z.
    Varga, L.
    Benedek, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A86 - A86
  • [45] Reduced D-dimer Levels In C1-esterase-inhibitor Hereditary Angioedema (C1-INH-HAE) Patients Treated With Subcutaneous C1-esterase-inhibitor (C1-INH[SC]): Findings From The COMPACT Study
    Reshef, Avner
    Cicardi, Marco
    Zuraw, Bruce L.
    Craig, Timothy
    Caballero, Teresa
    Lawo, John-Philip
    Jacobs, Iris
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB45 - AB45
  • [46] Complement component 1 inhibitor (C1-INH) like protein on murine spermatozoa:: Anti-C1-INH inhibits in vitro fertilization
    Pillai, S
    Jiang, HX
    Roudebush, WE
    Zhang, HM
    Waheba, M
    AUTOIMMUNITY, 1998, 28 (02) : 69 - 76
  • [47] Efficacy of lanadelumab in patients switching from long-term prophylaxis with C1-inhibitor (C1-INH): results from the phase 3 HELP Study
    Johnston, Douglas T.
    Anderson, John T.
    Schranz, Jennifer
    Nurse, Christina
    Cicardi, Marco
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB47 - AB47
  • [48] HEREDITARY ANGIOEDEMA C1-INH REPLACEMENT THERAPY AND COEXISTING AUTOIMMUNE DISORDERS: FINDINGS FROM A CLAIMS DATABASE
    Farkas, H.
    Fridman, M.
    Krishnarajah, S.
    Chiao, J.
    Machnig, T.
    Prusty, S.
    Berger, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S32 - S32
  • [49] Hereditary C1-inhibitor deficiency angioedema (C1-INH-HAE) in children - practical considerations
    Kucharczyk, Aleksandra
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2023, 19 (04): : 319 - 333
  • [50] Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
    Hurler, Lisa
    Toonen, Erik J. M.
    Kajdacsi, Erika
    van Bree, Bregje
    Brandwijk, Ricardo J. M. G. E.
    de Bruin, Wieke
    Lyons, Paul A.
    Bergamaschi, Laura
    Sinkovits, Gyorgy
    Cervenak, Laszlo
    Wuerzner, Reinhard
    Prohaszka, Zoltan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345